# Carbidopa and Levodopa

NDC: 59651-456
Generic name: Carbidopa and Levodopa
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20221128

FDA application: ANDA216537

## Active ingredients

- CARBIDOPA: 10 mg/1
- LEVODOPA: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-456"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-456
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ced8a05-27ac-463f-b331-387e473fdaa1